Daniel Loeb's position in Amedisys is currently worth $30.3M. That's 0.41% of their equity portfolio (35th largest holding). Daniel Loeb acquired their 300k shares in Q1 2009. So far they never sold any shares in the company. The stake costed the investor $11.7M, netting the investor a gain of 160% so far.